Reversible inhibition enzyme kinetics

If the inhibitor combines irreversibly with the enzyme—for example, by covalent attachment—the kinetic pattern seen is like that of noncompetitive inhibition, because the net effect is a loss of active enzyme. Usually, this type of inhibition can be distinguished from the noncompetitive, reversible inhibition case since the reaction of I with E (and/or ES) is not instantaneous. Instead, there is a time-dependent decrease in enzymatic activity as E + I El proceeds, and the rate of this inactivation can be followed. Also, unlike reversible inhibitions, dilution or dialysis of the enzyme inhibitor solution does not dissociate the El complex and restore enzyme activity. 

Another type of inhibitor combines with the enzyme at a site which is often different from the substrate-binding site and as a result will inhibit the formation of the product by the breakdown of the normal enzyme-substrate complex. Such non-competitive inhibition is not reversed by the addition of excess substrate and generally the inhibitor shows no structural similarity to the substrate. Kinetic studies reveal a reduced value for the maximum activity of the enzyme but an unaltered value for the Michaelis constant (Figure 8.7). There are many examples of non-competitive inhibitors, many of which are regarded as poisons because of the crucial role of the inhibited enzyme. Cyanide ions, for instance, inhibit any enzyme in which either an iron or copper ion is part of the active site or prosthetic group, e.g. cytochrome c oxidase (EC 1.9.3.1). 

Reversible Inhibition One common type of reversible inhibition is called competitive (Fig. 6-15a). A competitive inhibitor competes with the substrate for the active site of an enzyme. While the inhibitor (I) occupies the active site it prevents binding of the substrate to the enzyme. Many competitive inhibitors are compounds that resemble the substrate and combine with the enzyme to form an El complex, but without leading to catalysis. Even fleeting combinations of this type will reduce the efficiency of the enzyme. By taking into account the molecular geometry of inhibitors that resemble the substrate, we can reach conclusions about which parts of the normal substrate bind to the enzyme. Competitive inhibition can be analyzed quantitatively by steady-state kinetics. In the presence of a competitive inhibitor, the Michaelis-Menten equation (Eqn 6-9) becomes... 

Reversible inhibition occurs rapidly in a system which is near its equilibrium point and its extent is dependent on the concentration of enzyme, inhibitor and substrate. It remains constant over the period when the initial reaction velocity studies are performed. In contrast, irreversible inhibition may increase with time. In simple single-substrate enzyme-catalysed reactions there are three main types of inhibition patterns involving reactions following the Michaelis-Menten equation competitive, uncompetitive and non-competitive inhibition. Competitive inhibition occurs when the inhibitor directly competes with the substrate in forming the enzyme complex. Uncompetitive inhibition involves the interaction of the inhibitor with only the enzyme-substrate complex, while non-competitive inhibition occurs when the inhibitor binds to either the enzyme or the enzyme-substrate complex without affecting the binding of the substrate. The kinetic modifications of the Michaelis-Menten equation associated with the various types of inhibition are shown below. The derivation of these equations is shown in Appendix S.S. 

The primary considerations in studies of inhibition mechanisms are reversibility and selectivity. The inhibition kinetics of reversible inhibition give considerable insight into the reaction mechanisms of enzymes and, for that reason, have been well studied. In general, reversible inhibition involves no covalent binding, occurs rapidly, and can be reversed by dialysis or, more rapidly, by dilution. Reversible inhibition is usually divided into competitive inhibition, uncompetitive inhibition, and noncompetitive inhibition. Because these types are not rigidly separated, many intermediate classes have been described. 

Although OPPs and carbamates exhibit very similar modes of action in various animal species, i.e, acetylcholinesterase inhibition in the CNS with resulting paralysis—there is an important difference between the two classes of pesticides. Carbamates do not require metabolic conversion prior to exhibiting their toxicity. Furthermore the enzyme activity may at times be rapidly regenerated by reversal of inhibition. The kinetics of the inhibition (carbamoylation) reaction have been well studied in it electrophilic carbamoyl moieties form covalent bonds with enzyme esteratic sites. This is followed by carbamate transfer of an acidic group to the site to yield the acetylated enzyme complex (ref. 176). 

Over the past decade there has been a substantial improvement in the ability to predict metabolism-based in vivo drug interactions from kinetic data obtained in vitro. This advance has been most evident for interactions that occur at the level of cytochrome P450 (CYP)-catalyzed oxidation and reflects the availability of human tissue samples, cDNA-expressed CYPs, and well-defined substrates and inhibitors of individual enzymes. The most common paradigm in the prediction of in vivo drug interactions has been first to determine the enzyme selectivity of a suspected inhibitor and subsequently to estimate the constant that quantifies the potency of reversible inhibition in vitro. This approach has been successful in identifying clinically important potent competitive inhibitors, such as quinidine, fluoxetine, and itraconazole. However, there is a continuing concern that a number of well-established and clinically important CYP-mediated drug interactions are not predictable from the classical approach that assumes reversible mechanisms of inhibition are ubiquitous. 

Reversible inhibition can be competitive or non-competitive. Competitive inhibitors bind to the active site and compete with the substrate for binding to the enzyme. However this means that increasing the S concentration will progressively outcompete the inhibitor. Accordingly a Lineweaver—Burk analysis of enzyme kinetic data obtained in the presence or absence of a competitive inhibitor will yield the same Fmax (at infinite S concentration) but the Am in the presence of the inhibitor (A, ) will be higher (poorer binding) than the Am measured in the absence of competitive inhibitor. Knowing the inhibitor concentration [I] one can calculate the A) from the relation ... 

The various kinds of reversible inhibition that have been identified all depend on non-covalent binding, but inhibitors differ in how they act, with consequent differences in their kinetic effects. Figure 8-6 depicts a general scheme for enzyme inhibition of a simple single substrate-single product reaction. 

This article describes various approaches to inhibition of enzyme catalysis. Reversible inhibition includes competitive, uncompetitive, mixed inhibition, noncompetitive inhibition, transition state, and slow tight-binding inhibition. Irreversible inhibition approaches include affinity labeling and mechanism-based enzyme inhibition. The kinetics of the various inhibition approaches are summarized, and examples of each type of Inhibition are presented. 

The mode of action of inhibitors can be divided into two groups reversible or irreversible. A detailed explanation can be found in textbooks of enzyme kinetics and assays [345]. The critical aspects and kinetics of both mechanisms are summarized in Table 10.8. In brief, in all cases the presence of a substrate is a prerequisite and it has to be added at a concentration that does not hmit the reaction rate of the non-inhibited... 

In competitive inhibition some intermediate I competes with reactions for complexation with enzyme E. Adsorption is now reversible. The corresponding kinetic scheme is ... 

In textbooks dealing with enzyme kinetics, it is customary to distinguish four types of reversible inhibitions (i) competitive (ii) noncompetitive (iii) uncompetitive and, (iv) mixed inhibition. Competitive inhibition, e.g., given by the product which retains an affinity for the active site, is very common. Non-competitive inhibition, however, is very rarely encountered, if at all. Uncompetitive inhibition, i.e. where the inhibitor binds to the enzyme-substrate complex but not to the free enzyme, occurs also quite often, as does the mixed inhibition, which is a combination of competitive and uncompetitive inhibitions. The simple Michaelis-Menten equation can still be used, but with a modified Ema, or i.e. ... 

The inhibition of certain enzymes by specific metabolites is an important element in the regulation of intermediary metabolism and most often occurs with cooperative enzymes that are regulated allosterically. Inhibition of enzymes that obey the Michaelis-Menten equation, noncooperative enzymes, is more commonly used by pharmacists to alter a patient s metabolism. Reversible inhibition of noncooperative enzymes is classified into three groups which can be distinguished kinetically and which have different mechanisms and effects when administered. The classes are called competitive, uncompetitive, and noncompetitive inhibition. Mixed inhibition also occurs. In all these types of inhibition, the inhibitor (usually a small molecule) binds reversibly and rapidly with the enzyme. 

One mechanism intrinsic to virtually aU DNA polymerases is a separate 3 5 exonuclease activity that double-checks each nucleotide after it is added. This nuclease activity permits the enzyme to remove a newly added nucleotide and is highly specific for mismatched base pairs (Fig. 25-7). If the polymerase has added the wrong nucleotide, translocation of the enzyme to the position where the next nucleotide is to be added is inhibited. This kinetic pause provides the opportunity for a correction. The 3 5 exonuclease activity removes the mispaired nucleotide, and the polymerase begins again. This activity, known as proofreading, is not simply the reverse of the polymerization reaction (Eqn... 

Kinetic studies of reversible inhibition by substrate analogs give evidence of the mode of action of the inhibitor and the types of enzyme-inhibitor complex formed, and estimates of their dissociation constants. The complexes may be isolated and sometimes crystallized. Studies of the stabilities, optical properties, and structures of ternary complexes of enzymes, coenzymes, and substrate analog in particular, as stable models of the catalytically active ternary complexes or of the transition state for hydride transfer (61,79,109,115-117), can only be touched upon here there is direct evidence with several enzymes that the binding of coenzymes is firmer in such complexes than in their binary complexes (85,93,118), which supports the indirect, kinetic evidence already mentioned for a similar stabilization in active ternary complexes. 

Colman and Frieden (108) demonstrated in 1966 that acetylation of one amino group per subunit with acetic anhydride produces 80% inactivation. More extensive acetylation alters the degree of polymerization and certain kinetic parameters (276). Almost simultaneously, Anderson et al. (277) reported the reversible inhibition of GDH by pyridoxal 5 -phosphate and certain other aromatic aldehydes. The inhibition was attributed to formation of a Schilf base since reduction with NaBH4 results in irreversible inactivation. It was estimated that approximately one residue of -pyridoxyllysine had been formed per subunit. In 1969, Holbrook and Jeckel (278) inactivated the enzyme by reaction with a substituted maleimide and, subsequently, obtained the partial sequence of a tryptic peptide containing a modified lysine residue (Fig. 7). 

Reversibly formed micelles have long been of interest as models for enzymes, since they provide an amphipathic environment attractive to many substrates. Substrate binding (non-covalent), saturation kinetics and competitive inhibition are kinetic factors common to both enzyme reaction mechanism analysis and micellar binding kinetics. 

Guidelines issued by JMPR have drawn attention to the currently used methods for the determination of ChE activity that may lead to erroneous conclusions when applied to rapidly reversible ChE inhibitions (c.g., JV-methyl and N,N-dimethyl CMs). It has been suggested that in vitro kinetic studies should be made to elucidate the nature of reversible inhibition reactions and the results obtained from in vivo studies should be interpreted cautiously. The method for the determination of ChE inhibition of CMs i.s inadequate. Occasionally, data are inconsistent with respect to dose and the degree of ChE inhibition because CMs are reversible inhibitors of ChE with a short duration of action. Because of the reversible inhibition of the enzyme by dilution, as would occur during the preparation of the assay, inhibition cannot be accurately measured. JMPR has stressed that in order to permit evaluation of ChE inhibition by CMs in viva, special care is required in reporting all details of such studies. CM-induced ChE inhibition studies should utilize minimal dilution during the preparation of the assay, minimal incubation limes, and minimal times between blood sampling and assay (Ellman etui, 1967),... 

The rate of the reaction can then be derived in terms of and 4,ax (or = /max/[E]). From the knowledge of the dissociation constant and the rate constant for catalysis it is then possible to compare inhibitors and the dissociation constant for the inhibitors, K, in relation to the natural substrates and the effect on the catalytic rates. These kinetic parameters, k and (or K) can then give an indication as to the affinity (K versus and specificity (/general scheme of reversible inhibition, and Figure... 

Inhibition of enzymes can basically be divided into reversible or irreversible. According to inhibition kinetics, it can be divided into three types— competitive, non competitive, and allosteric. Competitive inhibition can be characterized by binding of the inhibitor to the active site of the enzyme (they are structurally similar to substrate) and inhibition can be reversed by substrate access (reversible inhibition). The reaction rate is dependent on the substrate and inhibitor concentrations and their affinity to the enzyme. Noncompetitive inhibition cannot be reversed by substrate access and the inhibitor reacts with other parts of the enzyme rather than the active site, and it is not structurally similar to the substrate. The enzymatic reaction can be irreversible when the affinity of the inhibitor to the enzyme is relatively high. Allosteric ligands (inhibitors or activators) are bound to quite another... 

Reversible inhibition by cyanide is only slowly expressed in a mixture of enzyme and substrate. While azide inhibition required approximately two minutes for full expression, cyanide may require as much as 15 minutes (7S5). As foimd with azide, preincubation of cyanide with the oxidized or reduced forms of the enzyme does not affect the lag time of inliibition. This suggests that cyanide does not inhibit by binding to either the fully oxidized or fully reduced protein. In contrast to azide, cyanide shows nominally competitive inhibition with substrate for an intermediate form of the enzyme. Since cyanide, like azide, binds very strongly to ceruloplasmin the use of mutual depletion kinetics has indicated that two cyanide molecules bind to ceruloplasmin in the fully inhibited form. 

Mechanisms of CYP inhibition can be broadly divided into two categories reversible inhibition and mechanism-based inactivation. Depending on the mode of interaction between CYP enzymes and inhibitors, reversible CYP inhibition is further characterized as competitive, noncompetitive, uncompetitive, and mixed (Ito et al., 1998b). Evaluation of reversible inhibition of CYP reactions is often conducted under conditions where M-M kinetics is obeyed. Based on the scheme illustrated in Fig. 5.1, various types of reversible inhibition are summarized in Table 5.1. Figure 5.1 depicts a simple substrate-enzyme complex during catalysis. In the presence of a reversible inhibitor, such a complex can be disrupted leading to enzyme inhibition. 

---